Acceleron Pharma
XLRN
#1586
Rank
NZ$19.07 B
Marketcap
$311.90
Share price
0.00%
Change (1 day)
16,053.29%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: NZ$19.07 Billion

As of February 2025 Acceleron Pharma has a market cap of NZ$19.07 Billion. This makes Acceleron Pharma the world's 1586th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$17.21 B7.58%
2021NZ$16.00 B49.8%
2020NZ$10.68 B155.45%
2019NZ$4.18 B39.24%
2018NZ$3.00 B11.11%
2017NZ$2.70 B94.38%
2016NZ$1.39 B-41.41%
2015NZ$2.37 B47.17%
2014NZ$1.61 B18.05%
2013NZ$1.36 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$273.09 B 1,331.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$128.49 B 573.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$655.99 B 3,339.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$36.47 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.42 B-97.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.64 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$252.44 B 1,223.49%๐Ÿ‡บ๐Ÿ‡ธ USA